Ben Oyler

COO, Nectar

As COO & co-founder of Nectar, Ben is leading an innovative and comprehensive solution to solve for millions suffering with allergies. Prior, Ben was COO of Helio Genomics, innovating in the early cancer testing using NGS methylation. Previously Ben was the VP of Strategy at Ancestry and lead the 2019 launch of their Health product and managed operations for the first 8 years of their DNA product.

All CES conference sessions are seated on a first-come, first-served basis.
VMD4-CES-PROD-1